Further, the expression level of Gpx2 was significantly higher in papillary or nodular hyperplasia (PNHP) and pure urothelial carcinoma (UC) lesions than in the normal epithelium of BBN + PEITC-treated rats. This evidence concerns the gene GPX2 and hyperplasia.